Gandara, D. R., Makharadze, T., Gümüş, M., Gogishvili, M., Sezer, A., Kim, E., . . . Quek, R. G. W. (2026). Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy. Cancers, 18(6), 916. https://doi.org/10.3390/cancers18060916
Chicago Style (17th ed.) CitationGandara, David R., et al. "Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy." Cancers 18, no. 6 (2026): 916. https://doi.org/10.3390/cancers18060916.
MLA (9th ed.) CitationGandara, David R., et al. "Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy." Cancers, vol. 18, no. 6, 2026, p. 916, https://doi.org/10.3390/cancers18060916.